Autor: "Da Rocha Fernandes JD" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Persistence with IDegLira in Patients in Clinical Practice: A Nationwide Observational Study in Sweden.
Autorzy:: Eliasson B; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden. .; Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden. .
Ekelund J; Centre of Registers Västra Götaland, Gothenburg, Sweden.
Miftaraj M; Centre of Registers Västra Götaland, Gothenburg, Sweden.
Ranthe MF; Novo Nordisk A/S, Søborg, Denmark.
Mårdby AC; Medical Affairs, Novo Nordisk, Malmö, Sweden.; Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Da Rocha Fernandes JD; Novo Nordisk A/S, Søborg, Denmark.
Svensson AM; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.; Pokaż więcej
Źródło:: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2020 Aug; Vol. 11 (8), pp. 1807-1820. Date of Electronic Publication: 2020 Jul 03.
Typ publikacji:: Journal Article

Czasopismo naukowe

Skocz do pozycji: 2.

Tytuł:: Glycemic Control Among Patients Newly Prescribed IDegLira Across Prior Therapy Group in US Real-World Practice.
Autorzy:: Egede LE; Medical College of Wisconsin, Milwaukee, WI, USA. .
Bogdanov A; Veradigm Health, San Francisco, CA, USA.
Fischer L; Veradigm Health, San Francisco, CA, USA.
Da Rocha Fernandes JD; Novo Nordisk, Søborg, Denmark.
Kallenbach L; Veradigm Health, San Francisco, CA, USA.; Pokaż więcej
Źródło:: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2020 Jul; Vol. 11 (7), pp. 1579-1589. Date of Electronic Publication: 2020 Jun 06.
Typ publikacji:: Journal Article

Czasopismo naukowe

Informacja